Hönemann Klaus-Dieter, Hofmann Steffen, Ritter Frank, Mönnig Gerold
Schuechtermann-Clinic, Department of Cardiology, Heart-Center Osnabrueck-Bad Rothenfelde, Ulmenallee 5-11, D-49214 Bad Rothenfelde, Germany.
Schuechtermann-Clinic, Department of Heart Surgery, Heart-Center Osnabrueck-Bad Rothenfelde, Ulmenallee 5-11, D-49214 Bad Rothenfelde, Germany.
Eur Heart J Case Rep. 2021 May 12;5(5):ytab097. doi: 10.1093/ehjcr/ytab097. eCollection 2021 May.
A rare, but serious, complication following transcatheter aortic valve replacement (TAVR) is the occurrence of an iatrogenic ventricular septal defect (VSD).
We describe a case of an 80-year-old female who was referred with severe aortic stenosis for TAVR. Following thorough evaluation, the heart team consensus was to proceed with implantation via a transapical approach of an ACURATE neo M 25 mm valve (Boston Scientific, Natick, MA, USA). The valve was deployed harnessing transoesophageal echocardiographic (TOE) guidance under rapid pacing with post-dilation. Directly afterwards a very high VSD close to the aortic annulus was detected. As the patient was haemodynamically stable, the procedure was ended. The next day another TOE revealed a shunt volume (left-to-right ventricle) between 50% and 60%. Because the defect was partly located between the stent struts of the ACURATE valve decision was made to fix this leakage with implantation of a further valve and we chose an EVOLUT Pro 29 mm (Medtronic Inc., Minneapolis, MN, USA). The valve-in-valve was implanted 2-3 mm below the lower edge of the first valve, more towards the left ventricular outflow tract (LVOT) with excellent result: VSD was reduced to a very small residual shunt without any hemodynamic relevance. Figure 3() Fluoroscopic image after transapical transcatheter aortic valve replacement (ACURATE neo M); () transoesophageal echocardiography following transapical transcatheter aortic valve replacement showing a severe ventricular septal defect; () angiography after valve-in-valve implantation. The implantation depth of the second valve (EVOLUT Pro 29 mm) was slightly deeper in the left ventricular outflow tract; and () transoesophageal echocardiography after the valve-in-valve procedure showing a small residual shunt. () Stentstruts, () tricuspid valve, and () leakage (ventricular septal defect). Pulmonary artery catheter, Pleural drain.Figure 4Left ventricular angiogram after valve-in-valve implantation showing a very small residual contrast shunt from the left-to-right ventricle (encircled). Pulmonary artery catheter, Pleural drain.
We suggest that an iatrogenic VSD located near the annulus may be treated percutaneously in a bail-out situation with implantation of a second valve that should be implanted slightly more into the LVOT to cover the VSD.
经导管主动脉瓣置换术(TAVR)后一种罕见但严重的并发症是医源性室间隔缺损(VSD)的发生。
我们描述了一例80岁女性患者,因严重主动脉瓣狭窄转诊接受TAVR治疗。经过全面评估,心脏团队一致认为应通过经心尖途径植入一枚25毫米的ACURATE neo M瓣膜(美国波士顿科学公司,马萨诸塞州纳蒂克)。在快速起搏和后扩张的情况下,利用经食管超声心动图(TOE)引导部署瓣膜。紧接着,在靠近主动脉瓣环处检测到一个非常大的室间隔缺损。由于患者血流动力学稳定,手术结束。第二天,再次进行TOE检查显示分流容积(从左心室到右心室)在50%至60%之间。由于缺损部分位于ACURATE瓣膜的支架支柱之间,决定通过植入另一枚瓣膜来修复这种渗漏,我们选择了一枚29毫米的EVOLUT Pro瓣膜(美国美敦力公司,明尼阿波利斯,明尼苏达州)。瓣膜内瓣膜植入在第一枚瓣膜下缘下方2 - 3毫米处,更靠近左心室流出道(LVOT),效果极佳:室间隔缺损缩小至非常小的残余分流,对血流动力学无任何影响。图3()经心尖经导管主动脉瓣置换术后(ACURATE neo M)的荧光透视图像;()经心尖经导管主动脉瓣置换术后经食管超声心动图显示严重的室间隔缺损;()瓣膜内瓣膜植入后的血管造影。第二枚瓣膜(29毫米的EVOLUT Pro)的植入深度在左心室流出道稍深一些;()瓣膜内瓣膜手术后经食管超声心动图显示小的残余分流。()支架支柱,()三尖瓣,()渗漏(室间隔缺损)。肺动脉导管,胸腔引流管。图4瓣膜内瓣膜植入后左心室血管造影显示从左心室到右心室有非常小的残余造影剂分流(圈出)。肺动脉导管,胸腔引流管。
我们建议,对于位于瓣环附近的医源性室间隔缺损,在紧急情况下可通过经皮植入第二枚瓣膜进行治疗,该瓣膜应稍微更多地植入左心室流出道以覆盖室间隔缺损。